Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000670077
Ethics application status
Not yet submitted
Date submitted
12/08/2010
Date registered
16/08/2010
Date last updated
16/08/2010
Type of registration
Prospectively registered
Titles & IDs
Public title
Establishing the occurence of non-O157 verocytotoxic Escherichia coli (VTEC) in New Zealand farming population using molecular and culture-based methods.
Query!
Scientific title
Establishing the occurence of non-O157 verocytotoxic Escherichia coli (VTEC) in patients presenting with sudden onset of diarrhoea in a New Zealand farming population using molecular and culture-based methods.
Query!
Secondary ID [1]
252433
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
gastroenteritis
257945
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
258112
258112
0
0
Query!
Normal oral and gastrointestinal development and function
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
The overall study period will be for 8 months. The trial will consist in obtaining faecal samples from an hospital laboratory which will then be sent to us for testing. The first phase will concist in an initial screen of the samples for VTEC using molecular methods. If the molecular scree is positive then the second phase will consist in isolating and characterising the VTEC from the faecal sample.
Query!
Intervention code [1]
257000
0
Early detection / Screening
Query!
Intervention code [2]
257020
0
Not applicable
Query!
Comparator / control treatment
Not applicable
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
258976
0
Establish occurence of non-O157 VTEC in New Zealand.The first phase of this project will look at optimising
(a) molecular-based methods for the detection of non-O157 STEC from clinical samples, and
(b) culture-based methods for the isolation of non-O157 STEC.
The second phase of this project will apply these methods to the screening of clinical samples obtained from a hospital
laboratory.
Query!
Assessment method [1]
258976
0
Query!
Timepoint [1]
258976
0
At the end of the clinical trial (at the end of the 8 months)
Query!
Secondary outcome [1]
265165
0
From the results obtained from the clinical trial we will be able to draw recommendations in the form of a final report as to which methods to use for the detection and isolation of non-O157 VTEC.
Query!
Assessment method [1]
265165
0
Query!
Timepoint [1]
265165
0
At the end of the clinicla trial (Will be in June 2011)
Query!
Eligibility
Key inclusion criteria
faecal samples submitted for general gastroenteritis screen and from HUS patients
Query!
Minimum age
No limit
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
No clearance samples
Query!
Study design
Purpose
Natural history
Query!
Duration
Cross-sectional
Query!
Selection
Convenience sample
Query!
Timing
Prospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
1/11/2010
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
150
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
2819
0
New Zealand
Query!
State/province [1]
2819
0
Query!
Funding & Sponsors
Funding source category [1]
257450
0
Government body
Query!
Name [1]
257450
0
Ministry of Research, Science and Technology
Query!
Address [1]
257450
0
Level 10, 2 The Terrace, PO Box 5336, Wellington 6145, New Zealand
Query!
Country [1]
257450
0
New Zealand
Query!
Primary sponsor type
Government body
Query!
Name
Institue of Environmental Science and Research Ltd (ESR)
Query!
Address
Kenepuru Science Centre
PO Box 50348
34 Kenepuru Drive
Porirua 5022
New Zealand
Query!
Country
New Zealand
Query!
Secondary sponsor category [1]
256681
0
None
Query!
Name [1]
256681
0
Query!
Address [1]
256681
0
Query!
Country [1]
256681
0
Query!
Ethics approval
Ethics application status
Not yet submitted
Query!
Ethics committee name [1]
259478
0
Query!
Ethics committee address [1]
259478
0
Query!
Ethics committee country [1]
259478
0
New Zealand
Query!
Date submitted for ethics approval [1]
259478
0
27/08/2010
Query!
Approval date [1]
259478
0
Query!
Ethics approval number [1]
259478
0
Query!
Summary
Brief summary
The faecal samples provided by volunteers will contribute to the research on toxigenic Escherichia coli also known as verocytotoxic E. coli or VTEC. They are over 150 different serotypes of VTEC which have been associated with diseases. The O157 serotype has been recognised since the 1980s as an important human pathogen causing outbreak overseas and serious sequalae such as haemolytic uremic syndrome or HUS. In New Zealand, O157 VTEC represent a significant burden and hospital, private and community laboratories have to report any case of O157 VTEC they detect. The other serotypes which are referred to as the non-O157 VTEC have become as important as the O157 VTEC in some overseas countries. In New Zealand, however, the true incidence of non-O157 VTEC is unknown as no routine surveillance is undertaken. This project will initially look at optimising the methods to detect and isolate VTEC. A clinical trial will then be undertaken which will look at (approximately)150 faecal samples from patients in the Waikato region. This pilot study will allow us to establish whether or not these non-O157 VTEC represent a health problem in New Zealand.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
31516
0
Query!
Address
31516
0
Query!
Country
31516
0
Query!
Phone
31516
0
Query!
Fax
31516
0
Query!
Email
31516
0
Query!
Contact person for public queries
Name
14763
0
Muriel Dufour
Query!
Address
14763
0
Institute of Environmental Science adn Research Ltd, National Centre for Biosecurity and Infectious Disease (ESR-NCBID) - Wallaceville
66 Ward Street
PO Box 40158
Upper Hutt 5018
New Zealand
Query!
Country
14763
0
New Zealand
Query!
Phone
14763
0
00 64 4 529 0607
Query!
Fax
14763
0
Query!
Email
14763
0
[email protected]
Query!
Contact person for scientific queries
Name
5691
0
Muriel Dufour
Query!
Address
5691
0
ESR-NCBID - Wallaceville
66 Ward Street
PO Box 40158
Upper Hutt 5018
New Zealand
Query!
Country
5691
0
New Zealand
Query!
Phone
5691
0
00 64 4 529 0607
Query!
Fax
5691
0
Query!
Email
5691
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF